2026 Global: High Intensity Focused Ultrasound Therapy Market -Competitive Review (2032) report
Description
The 2026 Global: High Intensity Focused Ultrasound Therapy Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Insightec Ltd., headquartered in Haifa, Israel, leads the MR-guided high-intensity focused ultrasound therapy segment with its ExAblate platform, which enables noninvasive ablation for neurological and oncological indications. EDAP TMS SA, based in Saint-Priest, France, complements this with its Sonablate and Focal One systems, delivering prostate and other organ ablations through focused ultrasound guided by real-time imaging. HistoSonics, Inc., located in Minneapolis, Minnesota, United States, is pursuing a histotripsy-based approach that uses controlled cavitation to mechanically fractionate tissue. Chongqing Haifu Medical Technology Co., Ltd., headquartered in Chongqing, China, remains a dominant Chinese supplier of HIFU devices for liver, kidney, pancreas, and other solid tumors, combining high-intensity ultrasound with specialized transducers. Together, these four companies illustrate the breadth of the HIFU landscape, spanning magnetic resonance, conventional ultrasound imaging guidance, and histotripsy paradigms, and collectively driving global clinical adoption through multi-continent partnerships and regulatory engagement. This quartet anchors a rapidly expanding global market.
SonaCare Medical LLC, based in Houston, United States, has long specialized in clinical HIFU for prostate therapy with its Sonablate devices, expanding into broader tumor ablation through collaborative trials and regulatory pathways. Misonix, Inc., headquartered in Farmingdale, United States, contributes with its ultrasonic energy platforms and focused-sonication capabilities that support preclinical research, neurosurgical applications, and translational oncology, positioning itself as a multidisciplinary player in the HIFU ecosystem. Alpinion Medical Systems Co., Ltd., headquartered in Seoul, South Korea, offers a portfolio of ultrasound systems and accessories that underpin HIFU integration in research and clinical settings, including systems tailored for interventional radiology and urology. The presence of these North American and Asian manufacturers demonstrates how HIFU therapy stretches across continents, enabling cross-border clinical trials, distributor networks, and localized service ecosystems that sustain device adoption, training, and reimbursement conversations. Each company maintains regional offices and partnerships to navigate regulatory requirements and evolving reimbursement landscapes in key markets.
Philips Healthcare, headquartered in Amsterdam, Netherlands, historically contributed to MR-guided focused ultrasound through its Sonalleve platform, integrating MRI with transcranial and body-focused ultrasound applications and setting regulatory benchmarks in several markets. Neusoft Medical Systems Co., Ltd., based in Shenyang, China, extends its ultrasound portfolio into interventional imaging and, in some regional lines, HIFU compatible systems for tumor ablation and research collaborations, reinforcing Asia's growing footprint in therapeutic ultrasound. Mindray Medical International Ltd., headquartered in Shenzhen, China, extends its global reach with an expansive line of diagnostic ultrasound equipment and research-oriented platforms, supporting multi-modality imaging and potential future HIFU integration in commercial settings. The continued involvement of these imaging and medical device leaders underscores the evolving ecosystem, with cross-disciplinary collaboration, regulatory harmonization, and innovations in energy delivery, targeting broader indications, improved patient safety, and more accessible noninvasive therapies across the globe. Market momentum will depend on robust clinical data and reimbursement.
Insightec Ltd., headquartered in Haifa, Israel, leads the MR-guided high-intensity focused ultrasound therapy segment with its ExAblate platform, which enables noninvasive ablation for neurological and oncological indications. EDAP TMS SA, based in Saint-Priest, France, complements this with its Sonablate and Focal One systems, delivering prostate and other organ ablations through focused ultrasound guided by real-time imaging. HistoSonics, Inc., located in Minneapolis, Minnesota, United States, is pursuing a histotripsy-based approach that uses controlled cavitation to mechanically fractionate tissue. Chongqing Haifu Medical Technology Co., Ltd., headquartered in Chongqing, China, remains a dominant Chinese supplier of HIFU devices for liver, kidney, pancreas, and other solid tumors, combining high-intensity ultrasound with specialized transducers. Together, these four companies illustrate the breadth of the HIFU landscape, spanning magnetic resonance, conventional ultrasound imaging guidance, and histotripsy paradigms, and collectively driving global clinical adoption through multi-continent partnerships and regulatory engagement. This quartet anchors a rapidly expanding global market.
SonaCare Medical LLC, based in Houston, United States, has long specialized in clinical HIFU for prostate therapy with its Sonablate devices, expanding into broader tumor ablation through collaborative trials and regulatory pathways. Misonix, Inc., headquartered in Farmingdale, United States, contributes with its ultrasonic energy platforms and focused-sonication capabilities that support preclinical research, neurosurgical applications, and translational oncology, positioning itself as a multidisciplinary player in the HIFU ecosystem. Alpinion Medical Systems Co., Ltd., headquartered in Seoul, South Korea, offers a portfolio of ultrasound systems and accessories that underpin HIFU integration in research and clinical settings, including systems tailored for interventional radiology and urology. The presence of these North American and Asian manufacturers demonstrates how HIFU therapy stretches across continents, enabling cross-border clinical trials, distributor networks, and localized service ecosystems that sustain device adoption, training, and reimbursement conversations. Each company maintains regional offices and partnerships to navigate regulatory requirements and evolving reimbursement landscapes in key markets.
Philips Healthcare, headquartered in Amsterdam, Netherlands, historically contributed to MR-guided focused ultrasound through its Sonalleve platform, integrating MRI with transcranial and body-focused ultrasound applications and setting regulatory benchmarks in several markets. Neusoft Medical Systems Co., Ltd., based in Shenyang, China, extends its ultrasound portfolio into interventional imaging and, in some regional lines, HIFU compatible systems for tumor ablation and research collaborations, reinforcing Asia's growing footprint in therapeutic ultrasound. Mindray Medical International Ltd., headquartered in Shenzhen, China, extends its global reach with an expansive line of diagnostic ultrasound equipment and research-oriented platforms, supporting multi-modality imaging and potential future HIFU integration in commercial settings. The continued involvement of these imaging and medical device leaders underscores the evolving ecosystem, with cross-disciplinary collaboration, regulatory harmonization, and innovations in energy delivery, targeting broader indications, improved patient safety, and more accessible noninvasive therapies across the globe. Market momentum will depend on robust clinical data and reimbursement.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
